Page last updated: 2024-10-28

hypericin and ER-Negative PR-Negative HER2-Negative Breast Cancer

hypericin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
De Souza, MVF1
Shinobu-Mesquita, CS1
Meirelles, LEF1
Mari, NL1
César, GB1
Gonçalves, RS1
Caetano, W1
Damke, E1
Silva, VR1
Damke, GM1
Consolaro, MEL1

Other Studies

1 other study available for hypericin and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Effects of hypericin encapsulated on Pluronic F127 photodynamic therapy against triple negative breast cancer.
    Asian Pacific journal of cancer prevention : APJCP, 2022, May-01, Volume: 23, Issue:5

    Topics: Anthracenes; Humans; Perylene; Photochemotherapy; Poloxamer; Triple Negative Breast Neoplasms

2022